eClinical Technology and Industy News

Kinetic River Corp. Receives First Japanese Patent for Time-Resolved Flow Cytometry

This issuance expands global protection for Kinetic River’s technologies aimed at expanding the power of flow cytometry

Excerpt from the Press Release:

MOUNTAIN VIEW, Calif., Oct. 1, 2021 /PRNewswire/ — Kinetic River Corp., a leader in custom flow cytometry instrumentation, announced today having been issued a patent from the Japanese Patent Office covering its innovative technologies for time-resolved flow cytometry. The official patent registration number is JP 6941053 B2, issued on September 7, 2021. This patent adds to a portfolio of 13 issued and 17 pending U.S. and international patents.

Flow cytometry is a powerful cell analysis tool with broad utility in research and clinical fields as diverse and important as tumor biology research, cancer and AIDS diagnostics, immunophenotyping, and cancer immunotherapy. Flow cytometry relies heavily on adding fluorescent labels to cells. The drive for simultaneous measurements of more and more such labels, the better to characterize cells in a sample, has been hitting both technological and operational barriers. Spectral crosstalk, due to the broad emission spectra of most common dyes used as labels, forces users to perform burdensome and costly compensation protocols. It also limits the number of dyes that can be measured simultaneously. Related constraints, such as autofluorescence background, limit the sensitivity of current assays.

Click the button below to read the entire Press Release:

Continue Reading The Press Release

Discover What Sets TrialStat Apart From Ordinary Data Management

Click the image or button below to explore our interactive infographic which illustrates the comprehensive and unique capabilities of the TrialStat eClinical Suite.

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?